Novartis

Exelon Patch

The Exelon Patch is indicated for patients with mild to severe Alzheimer’s Disease to improve nerve cells function.

Status: Completed

FDA Approved

 

Details

EMBARK

Aducanumab

Aducanumab is an anti-amyloid beta antibody made for patients with Alzheimer’s Disease.

Status: Completed

FDA Approved

Details